Elevance Health, Inc., formerly known as Anthem, Inc., operates as a behemoth in the U.S. managed healthcare industry, essentially acting as a central nervous system for millions navigating the labyrinthine world of medical care. The company's core mission, as they see it, is to improve the health of humanity, which, in practice, translates to providing a comprehensive suite of health plans and services. They offer commercial, Medicare, and Medicaid coverage, alongside a growing portfolio of clinical, behavioral, pharmacy, and complex-care solutions through brands like Anthem Blue Cross and Blue Shield, Wellpoint, and their healthcare services arm, Carelon. This integrated approach aims to connect physical, behavioral, and social needs, creating a "whole health" experience for approximately 115 million individuals across the nation.

Operating primarily within the U.S., Elevance Health leverages its formidable scale and exclusive Blue Cross and Blue Shield licenses in 14 states, granting it a significant local market presence that few competitors can replicate. Their business model thrives on recurring insurance premiums and administrative fees, essentially monetizing the complex dance between patients, providers, and payers. However, this intricate ballet isn't without its missteps. The company has found itself in the spotlight over historic debates, including a Justice Department lawsuit regarding alleged inaccurate Medicare Advantage billing practices and recent disputes with the Centers for Medicare & Medicaid Services (CMS) over data submission protocols, which even led to a $935 million set-aside for potential costs. Furthermore, a lawsuit against CMS in July 2026 highlighted disagreements over Medicare Advantage star ratings recalculations, with Elevance claiming a $115 million hit to future bonus payments. It seems that even the most meticulously "managed experience" can occasionally encounter a few... unexpected co-pays.